Mesa Laboratories MLAB Cash Flow Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| —— | $3.73M+338% | -$1.57M-154% | -$620K+68.6% | -$1.97M+99.2% | ||
| $5.25M-1.7% | $5.34M+3.2% | $5.18M-3.8% | $5.38M0.0% | $5.38M+0.4% | ||
| $17.87M+25.7% | $14.21M+1.0% | $14.07M-0.2% | $14.1M+7.3% | $13.14M+2.7% | ||
| —— | —— | —— | $2.97M+1.6% | $2.93M— | ||
| —— | —— | $2.86M+95.0% | $1.47M+227% | -$1.15M+36.2% | ||
| —— | —— | —— | —— | —— | ||
| $3.5M-42.7% | $6.1M+25.5% | $4.86M-2.1% | $4.97M-47.7% | $9.5M+918% | ||
| —— | -$5.17M+14.4% | -$6.04M-7.6% | -$5.61M-13.5% | -$4.95M— | ||
| —— | —— | —— | —— | —— | ||
| -$608K-140% | $1.52M+3,343% | -$47K-103% | $1.49M+399% | -$498K+94.2% | ||
| $18.02M-8.4% | $19.68M+0.3% | $19.62M-0.1% | $19.64M+2.6% | $19.15M+6.6% | ||
| $0— | $0— | $0— | $0-100% | $2.89M0.0% | ||
| $42.83M+3.1% | $41.53M+1.5% | $40.91M+7.8% | $37.96M-18.9% | $46.81M-0.5% | ||
| $3.25M-9.5% | $3.59M-2.2% | $3.67M-15.9% | $4.37M+2.8% | $4.25M+5.5% | ||
| $0-100% | $62.5K-50.0% | $125K-33.3% | $187.5K-25.0% | $250K+33.3% | ||
| -$3.25M+15.4% | -$3.84M+2.1% | -$3.92M+15.1% | -$4.62M-2.6% | -$4.5M-28.8% | ||
| $3.52M+0.4% | $3.51M+0.4% | $3.49M+0.5% | $3.48M+0.3% | $3.47M+0.2% | ||
| $36.75M-8.1% | $40M-1.8% | $40.75M-3.6% | $42.25M-4.5% | $44.25M+17.0% | ||
| -$41.85M+1.0% | -$42.29M+1.2% | -$42.79M+1.7% | -$43.52M+2.2% | -$44.51M— | ||
| $1.98M-27.0% | $2.72M— | —— | —— | —— | ||
| -$393K+80.2% | -$1.98M+49.4% | -$3.92M+45.6% | -$7.19M-705% | -$893K-133% | ||
| $18.02M-8.4% | $19.68M+0.3% | $19.62M-0.1% | $19.64M+2.6% | $19.15M+6.6% | ||
| $5.25M-1.7% | $5.34M+3.2% | $5.18M-3.8% | $5.38M0.0% | $5.38M+0.4% | ||
| —— | —— | —— | —— | —— | ||
| -$608K-140% | $1.52M+3,343% | -$47K-103% | $1.49M+399% | -$498K+94.2% | ||
| —— | $3.73M+338% | -$1.57M-154% | -$620K+68.6% | -$1.97M+99.2% | ||
| —— | -$5.17M+14.4% | -$6.04M-7.6% | -$5.61M-13.5% | -$4.95M— | ||
| $0-100% | $62.5K-50.0% | $125K-33.3% | $187.5K-25.0% | $250K+33.3% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $36.75M-8.1% | $40M-1.8% | $40.75M-3.6% | $42.25M-4.5% | $44.25M+17.0% | ||
| $0— | —— | —— | —— | —— | ||
| $1.98M-27.0% | $2.72M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $9.56M+33.3% | $7.17M+50.0% | $4.78M+100% | $2.39M— | $0— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $39.58M+4.3% | $37.94M+1.9% | $37.24M+10.9% | $33.59M-21.1% | $42.56M-1.0% | ||
| $39.58M+4.3% | $37.94M+1.9% | $37.24M+10.9% | $33.59M-21.1% | $42.56M-1.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Mesa Laboratories generate?
- Mesa Laboratories (MLAB) generated $42.8M in operating cash flow over the trailing twelve months.
- What is Mesa Laboratories's free cash flow?
- After $3.3M of capital expenditures, Mesa Laboratories's free cash flow was $39.6M over the trailing twelve months, down 7.0% year over year.
- Where does Mesa Laboratories's cash flow data come from?
- Every line is extracted from Mesa Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
